Apr 15 |
BTIG Research Predicts Over 118% Rally for These 3 Stocks
|
Apr 15 |
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
|
Apr 10 |
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
|
Apr 3 |
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
|
Mar 27 |
Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
|
Mar 12 |
Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics
|
Feb 28 |
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript
|
Feb 27 |
Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
|
Feb 27 |
Theravance Biopharma, Inc. (TBPH) Q4 2023 Earnings Call Transcript
|
Feb 27 |
Theravance Biopharma, Inc. 2023 Q4 - Results - Earnings Call Presentation
|